Cylene Pharmaceuticals preclinical data

In a mouse model of lymphoma, a single oral dose CX-5461 significantly reduced tumor burden in lymph nodes (p<0.01) and significantly reduced spleen size (p<0.001) at 24 hours post-treatment vs. vehic...